How do I evaluate peptide suppliers’ quality systems?
What quality management records, deviation procedures, change controls, complaint handling, and traceability systems should a laboratory assess during supplier qualification?
General Answer
Evaluating a peptide supplier's quality system is less about a single certificate and more about whether the supplier can prove control over time. The search notes provided are not relevant to peptide quality (they concern the English verb "do" and the MD vs. DO distinction), so the guidance below draws on standard supplier-qualification practice and domain knowledge. A laboratory should request documents and then verify them through a structured audit.
- Quality management records: Ask for the quality manual, standard operating procedures, batch production records, certificate of analysis (CoA) with method references, analytical raw data (HPLC, MS), stability data, and training and equipment-calibration logs. Confirm that records are contemporaneous, legible, and retained under a written retention policy.
- Deviation procedures: Request the deviation SOP and examples of recent deviations, including root-cause analysis, corrective and preventive action (CAPA), and closure evidence. Ask how out-of-specification results are handled and whether the lab can see trend reports.
- Change control: Confirm there is a formal change-control system covering process, equipment, suppliers, and specifications. Ask for a change notification commitment and a recent change log so the lab understands how changes are communicated and re-qualified.
- Complaint handling: Review the complaint SOP, response timelines, escalation paths, and examples of resolved complaints. Check whether complaints feed into CAPA and management review.
- Traceability: Verify lot-level traceability from raw material to finished vial, including supplier qualification of critical raw materials, unique lot numbers, and the ability to reconstruct a batch. Ask how the supplier handles recalls or simulated recalls.
- Audit and verification: Conduct a desk review, then an on-site or remote audit. Sample records rather than accepting summaries, interview operators, and check that document control prevents use of superseded versions. Consider third-party audit reports and proficiency-testing results.
- Ongoing monitoring: Set up a supplier scorecard covering on-time delivery, CoA accuracy, deviation frequency, and complaint resolution, and schedule periodic re-qualification.
For laboratories sourcing from Chinese peptide API or research-peptide manufacturers, our service items 8 and 9 cover finding, comparing, and evaluating Chinese peptide API factories and research-peptide raw-material factories; items 11 and 31 cover vialed lyophilized-powder factories; and items 12, 15, and 29 cover Chinese peptide international logistics providers. These comparisons can sit alongside the document and audit checklist above so the lab evaluates both quality systems and the surrounding supply chain.
In short: ask for records, test them against real examples, audit the system, and monitor it continuously. A supplier that cannot show deviation, change, complaint, and traceability evidence in practice has not demonstrated a functioning quality system, regardless of what its certificates say.
These answers are general industry information, not regulatory, medical or legal advice. Regulatory status, import rules and clinical suitability must be verified for the specific product, jurisdiction and intended use.